Baxter International Inc. (NYSE:BAX) Set to Present at J.P. Morgan Healthcare Conference

Core Viewpoint - Baxter International Inc. is preparing to present at the J.P. Morgan 2026 Healthcare Conference, which may influence its stock performance by providing insights into its future strategies and innovations [1] Group 1: Stock Performance - Evercore ISI maintains an "Outperform" rating for Baxter, with a revised price target of $23, indicating a potential upside of approximately 14.86% from the current stock price of $19.84 [2] - Baxter's current stock price is $20.59, reflecting a slight increase of 0.91% or $0.19, with fluctuations between $20.08 and $20.62 on the same day [3] - Over the past year, Baxter's stock has experienced significant volatility, with a high of $37.74 and a low of $17.40 [3] Group 2: Market Position - Baxter's market capitalization is approximately $10.58 billion, indicating its substantial presence in the healthcare market [4] - The trading volume for Baxter on the day is 9,514,299 shares, demonstrating active investor interest [4] - The upcoming presentation at the J.P. Morgan Healthcare Conference is highly anticipated, with stakeholders keenly observing for announcements that could impact stock trajectory [5]